Key Takeaways

A new study is testing a GLP-1 weight loss implant in 50 cats over six months

About 60% of U.S. cats are overweight, increasing their risk for diabetes and other problems

If successful, the treatment may cost pet owners around $100/month

SATURDAY, Dec. 6, 2025 (HealthDay News) — Weight loss drugs aren’t just for people anymore; They may soon be available for your furry friend.

A California company, Okava Pharmaceuticals , has launched a clinical trial testing a GLP-1–based weight loss treatment in 50 cats. The treatment uses a small under-the-skin implant, called OKV-119, designed to release medication slowly over six months.

The study, called MEOW-1, is one of the first of its kind.

According to the company, it "is designed to mimic many of the physiological effects

See Full Page